Health & Fitness
Health and Fitness
Health and Fitness
Mon, July 26, 2010Fri, July 23, 2010Thu, July 22, 2010Wed, July 21, 2010Tue, July 20, 2010Mon, July 19, 2010Sun, July 18, 2010Sat, July 17, 2010Fri, July 16, 2010Thu, July 15, 2010Wed, July 14, 2010Tue, July 13, 2010Mon, July 12, 2010Fri, July 9, 2010Thu, July 8, 2010Wed, July 7, 2010Tue, July 6, 2010Mon, July 5, 2010Fri, July 2, 2010Thu, July 1, 2010Illumina to Announce Second Quarter 2010 Financial Results on Tuesday, July 27, 2010
Published in Health and Fitness on Wednesday, July 14th 2010 at 3:21 GMT by Market Wire
SAN DIEGO--([ BUSINESS WIRE ])--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2010 following the close of market on Tuesday, July 27, 2010.
On the same day, at 2:00pm Pacific Time (5:00pm Eastern Time) Jay Flatley, president and chief executive officer, and Christian Henry, senior vice president, chief financial officer and general manager, Life Sciences, will host a conference call with analysts, investors and other interested parties to discuss financial and operating results.
Conference Call Details:
The conference call will begin at 2:00pm Pacific Time (5:00pm Eastern Time) on Tuesday, July 27, 2010. Interested parties may listen to the call by dialing 866.510.0710 (passcode: 84755429), or if outside North America, by dialing +1.617.597.5378 (passcode: 84755429). Individuals may access the live teleconference under the "Corporate/Investor Information" tab of Illumina's web site at [ www.illumina.com ].
A replay of the conference call will be available from 5:00pm Pacific Time (8:00pm Eastern Time) on July 27, 2010 through August 3, 2010 by dialing 888.286.8010, or if outside North America, by dialing +1.617.801.6888 (passcode: 99073585).
About Illumina
Illumina ([ http://www.illumina.com ]) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
